Industry: Machinery & Equipment
Published Date: 2025-02-25
Pages: 104 Pages
Report ld: 4230313
Request Sample
Customized Report
The global Cell therapy Processing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The North America Cell therapy Processing market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc., Immodulon-Therapeutics, Immunomedics Inc., etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Cell therapy Processing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell therapy Processing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell therapy Processing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Cell therapy Processing manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell therapy Processing revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Products
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy Processing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Cell therapy Processing Revenue Market Share by Region (2020-2025)
2.4 Global Cell therapy Processing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.2 Europe Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.3 China Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.4 Japan Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.6 India Cell therapy Processing Market Size and Prospective (2020-2031)
2.5.7 Central & South America Cell therapy Processing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Cell therapy Processing Historic Market Size by Type (2020-2025)
3.2 Global Cell therapy Processing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Cell therapy Processing Representative Players
4 Breakdown Data by Application
4.1 Global Cell therapy Processing Historic Market Size by Application (2020-2025)
4.2 Global Cell therapy Processing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Cell therapy Processing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Cell therapy Processing Players by Revenue (2020-2025)
5.1.2 Global Cell therapy Processing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Cell therapy Processing Revenue
5.4 Global Cell therapy Processing Market Concentration Analysis
5.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2024
5.5 Global Key Players of Cell therapy Processing Head office and Area Served
5.6 Global Key Players of Cell therapy Processing, Product and Application
5.7 Global Key Players of Cell therapy Processing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Cell therapy Processing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Cell therapy Processing Market Size by Type (2020-2025)
6.1.2.2 North America Cell therapy Processing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Cell therapy Processing Market Size by Application (2020-2025)
6.1.3.2 North America Cell therapy Processing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Cell therapy Processing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Cell therapy Processing Market Size by Type (2020-2025)
6.2.2.2 Europe Cell therapy Processing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Cell therapy Processing Market Size by Application (2020-2025)
6.2.3.2 Europe Cell therapy Processing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Cell therapy Processing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Cell therapy Processing Market Size by Type (2020-2025)
6.3.2.2 China Cell therapy Processing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Cell therapy Processing Market Size by Application (2020-2025)
6.3.3.2 China Cell therapy Processing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Cell therapy Processing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Cell therapy Processing Market Size by Type (2020-2025)
6.4.2.2 Japan Cell therapy Processing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Cell therapy Processing Market Size by Application (2020-2025)
6.4.3.2 Japan Cell therapy Processing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Cell therapy Processing Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Cell therapy Processing Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Cell therapy Processing Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Cell therapy Processing Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Cell therapy Processing Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Cell therapy Processing Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Cell therapy Processing Market Size by Type (2020-2025)
6.6.2.2 India Cell therapy Processing Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Cell therapy Processing Market Size by Application (2020-2025)
6.6.3.2 India Cell therapy Processing Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Anthrogenesis Corp.
7.1.1 Anthrogenesis Corp. Company Details
7.1.2 Anthrogenesis Corp. Business Overview
7.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
7.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2020-2025)
7.1.5 Anthrogenesis Corp. Recent Development
7.2 BioNTech
7.2.1 BioNTech Company Details
7.2.2 BioNTech Business Overview
7.2.3 BioNTech Cell therapy Processing Introduction
7.2.4 BioNTech Revenue in Cell therapy Processing Business (2020-2025)
7.2.5 BioNTech Recent Development
7.3 Cell Ideas
7.3.1 Cell Ideas Company Details
7.3.2 Cell Ideas Business Overview
7.3.3 Cell Ideas Cell therapy Processing Introduction
7.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2020-2025)
7.3.5 Cell Ideas Recent Development
7.4 Epic Sciences
7.4.1 Epic Sciences Company Details
7.4.2 Epic Sciences Business Overview
7.4.3 Epic Sciences Cell therapy Processing Introduction
7.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2020-2025)
7.4.5 Epic Sciences Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Cell therapy Processing Introduction
7.5.4 Roche Revenue in Cell therapy Processing Business (2020-2025)
7.5.5 Roche Recent Development
7.6 FuGENE
7.6.1 FuGENE Company Details
7.6.2 FuGENE Business Overview
7.6.3 FuGENE Cell therapy Processing Introduction
7.6.4 FuGENE Revenue in Cell therapy Processing Business (2020-2025)
7.6.5 FuGENE Recent Development
7.7 IBC Pharmaceuticals Inc.
7.7.1 IBC Pharmaceuticals Inc. Company Details
7.7.2 IBC Pharmaceuticals Inc. Business Overview
7.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
7.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.7.5 IBC Pharmaceuticals Inc. Recent Development
7.8 Bluebird Bio Inc.
7.8.1 Bluebird Bio Inc. Company Details
7.8.2 Bluebird Bio Inc. Business Overview
7.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
7.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.8.5 Bluebird Bio Inc. Recent Development
7.9 Immodulon-Therapeutics
7.9.1 Immodulon-Therapeutics Company Details
7.9.2 Immodulon-Therapeutics Business Overview
7.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
7.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2020-2025)
7.9.5 Immodulon-Therapeutics Recent Development
7.10 Immunomedics Inc.
7.10.1 Immunomedics Inc. Company Details
7.10.2 Immunomedics Inc. Business Overview
7.10.3 Immunomedics Inc. Cell therapy Processing Introduction
7.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.10.5 Immunomedics Inc. Recent Development
7.11 Juno Therapeutics Inc.
7.11.1 Juno Therapeutics Inc. Company Details
7.11.2 Juno Therapeutics Inc. Business Overview
7.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
7.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.11.5 Juno Therapeutics Inc. Recent Development
7.12 Medlmmune Inc.
7.12.1 Medlmmune Inc. Company Details
7.12.2 Medlmmune Inc. Business Overview
7.12.3 Medlmmune Inc. Cell therapy Processing Introduction
7.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.12.5 Medlmmune Inc. Recent Development
7.13 NeoStem Oncology
7.13.1 NeoStem Oncology Company Details
7.13.2 NeoStem Oncology Business Overview
7.13.3 NeoStem Oncology Cell therapy Processing Introduction
7.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2020-2025)
7.13.5 NeoStem Oncology Recent Development
7.14 Neurotech USA
7.14.1 Neurotech USA Company Details
7.14.2 Neurotech USA Business Overview
7.14.3 Neurotech USA Cell therapy Processing Introduction
7.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2020-2025)
7.14.5 Neurotech USA Recent Development
7.15 Novartis
7.15.1 Novartis Company Details
7.15.2 Novartis Business Overview
7.15.3 Novartis Cell therapy Processing Introduction
7.15.4 Novartis Revenue in Cell therapy Processing Business (2020-2025)
7.15.5 Novartis Recent Development
7.16 Persimmune Inc.
7.16.1 Persimmune Inc. Company Details
7.16.2 Persimmune Inc. Business Overview
7.16.3 Persimmune Inc. Cell therapy Processing Introduction
7.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.16.5 Persimmune Inc. Recent Development
7.17 Pluristem Therapeutics
7.17.1 Pluristem Therapeutics Company Details
7.17.2 Pluristem Therapeutics Business Overview
7.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
7.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2020-2025)
7.17.5 Pluristem Therapeutics Recent Development
7.18 BioMed Valley Discoveries Inc.
7.18.1 BioMed Valley Discoveries Inc. Company Details
7.18.2 BioMed Valley Discoveries Inc. Business Overview
7.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
7.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.18.5 BioMed Valley Discoveries Inc. Recent Development
7.19 Regeneron Pharmaceuticals Inc.
7.19.1 Regeneron Pharmaceuticals Inc. Company Details
7.19.2 Regeneron Pharmaceuticals Inc. Business Overview
7.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
7.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2020-2025)
7.19.5 Regeneron Pharmaceuticals Inc. Recent Development
7.20 UCL Business PLC.
7.20.1 UCL Business PLC. Company Details
7.20.2 UCL Business PLC. Business Overview
7.20.3 UCL Business PLC. Cell therapy Processing Introduction
7.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2020-2025)
7.20.5 UCL Business PLC. Recent Development
8 Cell therapy Processing Market Dynamics
8.1 Cell therapy Processing Industry Trends
8.2 Cell therapy Processing Market Drivers
8.3 Cell therapy Processing Market Challenges
8.4 Cell therapy Processing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 133
USD 3950.00
(Single User License)
The global Cell therapy Processing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 124
USD 2900.00
(Single User License)
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-30
Pages: 153
USD 4900.00
(Single User License)
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 136
USD 3950.00
(Single User License)
The global market for Cell therapy Processing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 94
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Cell therapy Processing Market
Published Date: 2024-04-25
Pages: 128
USD 4900.00
(Single User License)
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 101
USD 2900.00
(Single User License)
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 133
The global Cell therapy Processing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 124
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-30
Pages: 153
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 136
The global market for Cell therapy Processing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 94
Market Analysis and Insights: Global Cell therapy Processing Market
Published: 2024-04-25
Pages: 128
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 101
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now